The proposed bill establishes a wholesale prescription drug importation program in Michigan, aimed at allowing licensed drug wholesalers to import prescription drugs from Canadian suppliers. The program is designed to comply with federal safety and cost-saving requirements, ensuring that only drugs meeting U.S. Food and Drug Administration standards are imported. It mandates that the Department of Health and Human Services contract with licensed wholesalers to seek federal certification for the program and outlines specific conditions, such as prohibiting the importation of generic drugs that would violate U.S. patent laws and ensuring significant cost reductions for consumers.

Additionally, the bill requires the department to develop a registration process for health insurers, pharmacies, and healthcare providers wishing to participate in the program, as well as to maintain a public list of the wholesale acquisition costs of imported drugs. The department is also tasked with preparing annual reports on the program's operations, including details on drug participation, the number of prescriptions dispensed, and estimated cost savings. Furthermore, the bill allows the department to consult with the attorney general to monitor potential anticompetitive behavior and grants the authority to promulgate rules necessary for the program's implementation.